Pareto Securities Healthcare Conference: Mendus' cellular immunotherapy has been making progress in numerous cancers - being thoughtful about the setting and goal of treatment have been keys

Pareto Securities Healthcare Conference: Mendus' cellular immunotherapy has been making progress in numerous cancers - being thoughtful about the setting and goal of treatment have been keys2 Sept8 min

Listen on SpotifyAlso works in your browser

Apple PodcastsOpen
YouTubeOpen
Pocket Castsopens the podcast
Amazon Musicopens the podcast
Deezeropens the podcast

5 more apps

Overcastopens the podcast
Player FMopens the podcast
Castroopens the podcast
Podcast Addictopens the podcast
RSSopens the podcast

<p>CEO Erik Manting describes vididencel and the progress the company has been making in AML, CML, and ovarian cancer. Additional CML data is expected in this second half of the year.</p>